Risk factors and outcomes of bloodstream infections with metallo-β-lactamase-producing Acinetobacter

References

• Jones RN, Kirby JT, Beach ML, Biedenbach DJ, Pfaller MA. Geographic variations in activity of broad-spectrum ß-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997–2000). Diagn Microbiol Infect Dis 2002; 43: 239–43
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Jones RN. MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections. MYSTIC Study Group (Americas). J Antimicrob Chemother 2000; 46(Suppl T2)25–37
   Google Scholar
• Arakawa Y, Murakami M, Suzuki K, Ito H, Wacharotayankun R, Ohsuka S, et al. A novel integron-like element carrying the metallo-ß-lactamase gene blaIMP. Antimicrob Agents Chemother 1995; 39: 1612–5
   PubMed Web of Science ®Google Scholar
• Yan JJ, Hsueh PR, Ko WC, Luh KT, Tsai SH, Wu HM, et al. Metallo-ß-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother 2001; 45: 2224–8
   PubMed Web of Science ®Google Scholar
• Lauretti L, Riccio ML, Mazzariol A, Cornaglia G, Amicosante G, Fontana R, et al. Cloning and characterization of blaVIM, a new integron-borne metallo-ß-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 1999; 43: 1584–90
   PubMed Web of Science ®Google Scholar
• Lee K, Lim JB, Yum JH, Yong D, Chong Y, Kim JM, et al. bla(VIM-2) cassette-containing novel integrons in metallo-ß-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital. Antimicrob Agents Chemother 2002; 46: 1053–8
   PubMed Web of Science ®Google Scholar
• Marra AR, Pereira CA, Gales AC, Menezes LC, Cal RG, de Souza JM, et al. Bloodstream infections with metallo-ß-lactamase-producing Pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes. Antimicrob Agents Chemother 2006; 50: 388–90
   PubMed Web of Science ®Google Scholar
• Richet HM, Mohammed J, McDonald LC, Jarvis WR. Building communication networks: international network for the study and prevention of emerging antimicrobial resistance. Emerg Infect Dis 2001; 7: 319–22
   PubMedGoogle Scholar
• Bush K. New ß-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 2001; 32: 1085–9
   PubMed Web of Science ®Google Scholar
• Jacoby GA, Munoz-Price LS. The new ß-lactamases. N Engl J Med 2005; 352: 380–91
   PubMed Web of Science ®Google Scholar
• Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002; 8: 321–31
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial disk susceptibility testing: 16th informational supplement 2007; M100-S17, Wayne, PA, USA.
   Google Scholar
• Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH. Modified Hodge and EDTA-disk synergy tests to screen metallo-ß-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 2001; 7: 88–91
   PubMed Web of Science ®Google Scholar
• Lee K, Yum JH, Yong D, Lee HM, Kim HD, Docquier JD, et al. Novel acquired metallo-ß-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 2005; 49: 4485–91
   PubMed Web of Science ®Google Scholar
• Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233–9
   PubMed Web of Science ®Google Scholar
• Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1998. Am J Infect Control 1988; 16: 128–40
   PubMed Web of Science ®Google Scholar
• Castanheira M, Toleman MA, Jones RN, Schmidt FJ, Walsh TR. Molecular characterization of a ß-lactamase gene, blaGIM-1, encoding a new subclass of metallo-ß-lactamase. Antimicrob Agents Chemother 2004; 48: 4654–61
   PubMed Web of Science ®Google Scholar
• Jones RN, Biedenbach DJ, Sader HS, Fritsche TR, Toleman MA, Walsh TR. Emerging epidemic of metallo-ß-lactamase-mediated resistances. Diagn Microbiol Infect Dis 2005; 51: 77–84
   PubMed Web of Science ®Google Scholar
• Walsh TR, Toleman MA, Hryniewicz W, Bennett PM, Jones RN. Evolution of an integron carrying blaVIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program. J Antimicrob Chemother 2003; 52: 116–9
   PubMedGoogle Scholar
• Watanabe M, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991; 35: 147–51
   PubMed Web of Science ®Google Scholar
• Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-ß-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 2000; 44: 891–7
   PubMed Web of Science ®Google Scholar
• Lee SO, Kim NJ, Choi SH, Hyong Kim T, Chung JW, Woo JH, et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents Chemother 2004; 48: 224–8
   PubMed Web of Science ®Google Scholar
• Cisneros JM, Rodriguez-Bano J, Fernandez-Cuenca F, Ribera A, Vila J, Pascual A, et al. Risk factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clin Microbiol Infect 2005; 11: 874–9
   PubMed Web of Science ®Google Scholar
• Baran G, Erbay A, Bodur H, Onguru P, Akinci E, Balaban N, , et al. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. Int J Infect Dis 2008;12:16–21.
   PubMed Web of Science ®Google Scholar
• Katragkou A, Kotsiou M, Antachopoulos C, Benos A, Sofianou D, Tamiolaki M, et al. Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: a case-control study. Intensive Care Med 2006; 32: 1384–91
   PubMed Web of Science ®Google Scholar
• Hirakata Y, Yamaguchi T, Nakano M, Izumikawa K, Mine M, Aoki S, et al. Clinical and bacteriological characteristics of IMP-type metallo-ß-lactamase-producing Pseudomonas aeruginosa. Clin Infect Dis 2003; 37: 26–32
   PubMed Web of Science ®Google Scholar
• Zavascki AP, Barth AL, Gaspareto PB, Goncalves AL, Moro AL, Fernandes JF, et al. Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-ß-lactamase in 2 tertiary-care teaching hospitals. J Antimicrob Chemother 2006; 58: 882–5
   PubMedGoogle Scholar